The ARF6-based pathway plays a significant role in vascular ECs, may affect the CNS as well as tumor malignancy, and targeting ARF6 or components of its downstream signaling pathways may have extensive therapeutic implications for many diseases. This evidence concerns the gene ARF6 and neoplasm.